Charities have already been hit hard by the coronavirus pandemic and lockdown, and Cancer Research UK says it could have to cut £150 million from much-needed research funding a
Public and patient involvement (PPI) in clinical research is the new normal, but bridging the gap between how industry and charities work isn’t always easy.
Collaboration between pharma and patient organisations can yield fantastic results – but conflict of interest concerns can stop such potential-filled partnerships getting off the ground.
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas